STAT3 and neoplasm: Napabucasin was discovered and originally identified to be a cancer stemness inhibitor by suppressing the signal transducer and activator of transcription 3 (STAT3) [7], whose phosphorylation till pSTAT3 triggers the transcription of genes implicated in promoting tumor growth and survival and in regulating inflammation in the tumor microenvironment.